Victory Capital Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $297K | Buy |
20,361
+162
| +0.8% | +$1.56K | ﹤0.01% | 2172 |
|
|
2026
Q1 | $150K | Buy |
20,199
+1,348
| +7% | +$14.2K | ﹤0.01% | 2233 |
|
|
2025
Q4 | $222K | Buy |
18,851
+573
| +3% | +$6.18K | ﹤0.01% | 2179 |
|
|
2025
Q3 | $141K | Sell |
18,278
-5,209
| -22% | -$36.5K | ﹤0.01% | 2258 |
|
|
2025
Q2 | $172K | Sell |
23,487
-162
| -0.7% | -$1.31K | ﹤0.01% | 2272 |
|
|
2025
Q1 | $224K | Sell |
23,649
-378
| -2% | -$4.72K | ﹤0.01% | 2198 |
|
|
2024
Q4 | $396K | Sell |
24,027
-376
| -2% | -$5.84K | ﹤0.01% | 2088 |
|
|
2024
Q3 | $360K | Sell |
24,403
-2,071
| -8% | -$32.4K | ﹤0.01% | 2091 |
|
|
2024
Q2 | $367K | Sell |
26,474
-318
| -1% | -$4.51K | ﹤0.01% | 2050 |
|
|
2024
Q1 | $421K | Sell |
26,792
-23,839
| -47% | -$368K | ﹤0.01% | 2035 |
|
|
2023
Q4 | $819K | Buy |
50,631
+497
| +1% | +$8.13K | ﹤0.01% | 1805 |
|
|
2023
Q3 | $617K | Buy |
50,134
+28,438
| +131% | +$423K | ﹤0.01% | 1889 |
|
|
2023
Q2 | $349K | Buy |
21,696
+30
| +0.1% | +$494 | ﹤0.01% | 2073 |
|
|
2023
Q1 | $377K | Sell |
21,666
-4,925
| -19% | -$70.2K | ﹤0.01% | 2076 |
|
|
2022
Q4 | $246K | Sell |
26,591
-39,746
| -60% | -$371K | ﹤0.01% | 2217 |
|
|
2022
Q3 | $571K | Sell |
66,337
-420
| -0.6% | -$4.17K | ﹤0.01% | 1983 |
|
|
2022
Q2 | $544K | Sell |
66,757
-28,090
| -30% | -$268K | ﹤0.01% | 2017 |
|
|
2022
Q1 | $896K | Buy |
94,847
+11,684
| +14% | +$246K | ﹤0.01% | 1866 |
|
|
2021
Q4 | $2.84M | Sell |
83,163
-462,445
| -85% | -$18.1M | ﹤0.01% | 1451 |
|
|
2021
Q3 | $26.3M | Buy |
545,608
+122,020
| +29% | +$5.65M | 0.03% | 783 |
|
|
2021
Q2 | $19.1M | Buy |
423,588
+297,845
| +237% | +$13.2M | 0.02% | 912 |
|
|
2021
Q1 | $6.06M | Buy |
125,743
+32,924
| +35% | +$1.71M | 0.01% | 1276 |
|
|
2020
Q4 | $5M | Sell |
92,819
-4,508
| -5% | -$204K | 0.01% | 1241 |
|
|
2020
Q3 | $3.59M | Sell |
97,327
-1,343
| -1% | -$49.9K | ﹤0.01% | 1267 |
|
|
2020
Q2 | $3.06M | Sell |
98,670
-175,837
| -64% | -$4.87M | ﹤0.01% | 1304 |
|
|
2020
Q1 | $7.58M | Sell |
274,507
-5,988
| -2% | -$179K | 0.01% | 974 |
|
|
2019
Q4 | $8.2M | Sell |
280,495
-34,927
| -11% | -$832K | 0.01% | 1066 |
|
|
2019
Q3 | $6.03M | Buy |
315,422
+255,662
| +428% | +$6M | 0.01% | 1128 |
|
|
2019
Q2 | $1.31M | Hold |
59,760
| – | – | ﹤0.01% | 1250 |
|
|
2019
Q1 | $1.22M | Sell |
59,760
-17,790
| -23% | -$309K | ﹤0.01% | 1209 |
|
|
2018
Q4 | $978K | Sell |
77,550
-116,550
| -60% | -$1.74M | ﹤0.01% | 1226 |
|
|
2018
Q3 | $2.98M | Buy |
+194,100
| New | +$2.68M | 0.01% | 1014 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
Victory Capital Management's NEO Position: Q2 2026 in Review
Victory Capital Management increased its NeoGenomics (NEO) stake by 0.8% in Q2 2026, buying an estimated $1.56K and bringing the position to 20,361 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #2172.
Victory Capital Management first reported a position in NEO in Q3 2018 and has held it in 32 quarters since. The position peaked at $26.3M in Q3 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Victory Capital Management held 20,361 shares of NeoGenomics worth $297K as of Q2 2026.
- Victory Capital Management bought 162 NeoGenomics shares in Q2 2026, an estimated $1.56K.
- NeoGenomics made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2172 holding.
- Victory Capital Management first reported a position in NeoGenomics in Q3 2018 and has held it in 32 quarters since.
- Victory Capital Management's NeoGenomics position peaked at $26.3M in Q3 2021.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.